Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy - Wikidata - wikimedia - TriplyDB

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

http://www.wikidata.org/entity/Q36696647

about

Improving the clinical impact of biomaterials in cancer immunotherapy.Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy Stimulating antitumor immunity with nanoparticles Synthetic Nanoparticles for Vaccines and Immunotherapy Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.Towards programming immune tolerance through geometric manipulation of phosphatidylserine.Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery.The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer.Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cells.Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.Hydrogels and scaffolds for immunomodulation Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy.Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.Biophysical characterization of small molecule antiviral-loaded nanolipogels for HIV-1 chemoprophylaxis and topical mucosal application.Development of individualized anti-metastasis strategies by engineering nanomedicines Synthesis of Nanogels via Cell Membrane-Templated Polymerization.Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.Biomaterial Strategies for Immunomodulation.Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice.Active drug encapsulation and release kinetics from hydrogel-in-liposome nanoparticles Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.Lymphatic vessels and tertiary lymphoid organs.Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles.Overendocytosis of superparamagnetic iron oxide particles increases apoptosis and triggers autophagic cell death in human osteosarcoma cell under a spinning magnetic field Lipid-enveloped hybrid nanoparticles for drug delivery.Melanoma immunotherapy: historical precedents, recent successes and future prospects.Immunotherapy for the management of advanced melanoma: the next steps.Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications.Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Specific protein markers for stem cell cross-talk with neighboring cells in the environment.Manipulating the intersection of angiogenesis and inflammation Lipid-coated polymeric nanoparticles for cancer drug delivery.Nanotechnology for protein delivery: Overview and perspectives.

P2860

Q26766267-006B6963-0F8A-4BE6-BC61-E0AF6958933E Q27002646-C2E2CDB4-CD9E-4A79-A7B4-96DD15D7D460 Q27027780-811617FE-C9E0-4F5C-8E79-168C65A38205 Q28085375-5111D761-83DF-40D6-B744-CF01FA32EA9E Q28394719-1D127633-9488-4342-B5D9-C7C5E55A3574 Q28834339-CAD226CC-7135-4265-A734-9DC5C11B297C Q30279055-83981173-7479-4AF7-B3EE-9D28495C5D50 Q30751004-63BD3530-B27E-4865-9923-BFFC9F3E2333 Q33553465-259F2A78-5396-4175-B04F-2011C5F09816 Q33734382-62F8C31F-D63F-457B-950A-5B690B31BA2C Q33815087-624A8790-FEC0-4E29-A20D-FEB9573BB26B Q34428078-0431385A-FB54-4CB2-945A-6638087A74BE Q34479313-8696A1EE-1FB6-47F3-9D5D-BA8F9D322089 Q34563034-59B49119-0ED0-4818-A43F-0455488DCC8C Q34675068-F850C6DB-88A3-4301-9A4B-5F75B31C02DF Q34725541-01BF81EF-9BFF-4F66-88FC-3CB6BF7E4DD2 Q35053924-6AF7C0E1-0009-48D2-A218-3EC5A4F36EF8 Q35684362-A7BC000B-EBAC-488B-AB2F-6B98D6FAE3ED Q35947035-01FAEEFF-5A7F-4B7C-B230-DE4BA2CFEE2B Q35967474-6BB5A9AE-D50A-4EBA-B70C-926B8CC67779 Q36037531-80F363D8-503B-4DDB-AA6A-39D9DEBC22B2 Q36269694-EFF4B85C-420C-459C-965C-6D71F8CA3CCB Q36703124-417FFDFC-1D69-4FE2-8FAD-65E325E94C92 Q36733468-9C51F36E-FC45-483F-BF96-F3F1AFA1BB37 Q37029578-FB38FB76-C212-4EC3-92F6-D01D2CF3362F Q37148313-C7926F23-554C-4D35-AFAD-4E1DBD8A8341 Q37582113-8789840A-1B02-4F0B-9C36-786018D65A57 Q37602241-7EB07F46-6224-41F1-BCEB-0273C96FD7ED Q37625459-A5513F99-9167-4EC9-B1F0-176E5EBEAC8F Q37705979-312CA3E4-C89D-428E-A8AB-12DAA6C23A6A Q38071910-30068A21-9F5C-45FC-995C-51660D385D50 Q38081911-C5942DB5-E7C5-4C72-8585-F961DBCD35D0 Q38091675-91FF4442-D1D0-47FA-ADB1-DA8B9053EDFE Q38109107-08B789EA-96B2-4FCE-94C0-5E8E9CD47254 Q38110273-44F7603C-071C-4760-8A23-554DEA4C03C8 Q38150118-63E78194-283A-45BD-874A-289D39217DB8 Q38175402-F274E543-13D2-4153-BC1E-3C2255160A2B Q38260351-E606DC04-24D6-46C6-B294-19ED4FBE5798 Q38556750-EAB4B64B-8D63-411C-BCDC-4E51647C8764 Q38605185-1337AE2E-4E0A-4798-BCC0-F0C7B3312BD8

P2860

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

http://www.wikidata.org/entity/Q36696647

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Combination delivery of TGF-β ...... enhances tumour immunotherapy

@ast

Combination delivery of TGF-β ...... enhances tumour immunotherapy

@en

type

label

Combination delivery of TGF-β ...... enhances tumour immunotherapy

@ast

Combination delivery of TGF-β ...... enhances tumour immunotherapy

@en

prefLabel

Combination delivery of TGF-β ...... enhances tumour immunotherapy

@ast

Combination delivery of TGF-β ...... enhances tumour immunotherapy

@en

P1433

Q36696647-C8FEA8C8-9028-4648-B01C-1C9DB6D312EB

P1476

Q36696647-A3ABA309-CC04-4812-A2DC-F9D456BB31A0

P2093

Q36696647-0E345362-8D0F-42DB-BAC0-F9172BE776E3

Q36696647-426FD188-2510-400B-BA2C-E78C7E709861

Q36696647-6E4DFACD-DDE2-436C-A3B6-C3879C453B7C

Q36696647-951316F3-5CE1-41A4-9D33-BEDFC3FE64D8

Q36696647-968D67A3-9711-4DE8-86C5-5705B9A48DAE

Q36696647-96C8F404-D4D8-479A-8869-0C9E78744E03

Q36696647-9BA9C6F6-72F2-4642-B0CA-48BAF151CBFA

Q36696647-A1CC977C-425C-476F-B7D5-202CC213615E

Q36696647-A26310BA-E8B7-42DB-A2AD-65F30CC6871B

Q36696647-A9FC0801-05D0-44B7-BC75-494117472277

P2860

Q36696647-025A7931-3095-4CA0-AE6F-F4A3499327D1

Q36696647-1578499B-77ED-4D8F-8D60-CE2049D3F90F

Q36696647-167ACCD7-6CFB-4E22-9649-42FB760E5BC9

Q36696647-16A1FC10-E5E3-4812-AF88-9423D56E7B56

Q36696647-1B4B6AD0-38B2-43AF-B1DC-DD207257F73A

Q36696647-1C7F441B-192C-444A-AC08-44D44EB0AF82

Q36696647-24052C66-16D8-4AF7-A8C2-8423888D5E08

Q36696647-2CA36652-09D9-4066-B656-5C71B97FA805

Q36696647-349F479A-49C7-4F8E-9E32-64919180A7A5

Q36696647-3C26673F-29A7-45DA-B6DA-33EA5A17A971

P2888

Q36696647-63E19EC5-57EF-404A-8EA8-0AE50FC96830

P304

Q36696647-5F50564B-168C-4E60-A3A0-82377EA064FA

P31

Q36696647-491898FF-BD8B-4CFA-B3D1-90F5D0FB5B8F

P356

Q36696647-ED6CEE60-AF53-4437-A485-596DDC995E6D

P407

Q36696647-99C7996B-7608-468F-960A-C86FC1DDD5E2

P433

Q36696647-7E4061BC-DC22-437F-B96A-3643580FB954

P478

Q36696647-686BA5C7-A8B9-443C-8DBE-F576B023C053

P50

Q36696647-6D6FE607-0E07-4E87-AF07-F39FC3C79363

Q36696647-DA3F3855-7B25-4416-ACBD-66DC84E58DE2

P577

Q36696647-62D52104-49C7-4312-8F11-85BB2BEBB53C

P5875

Q36696647-E5C975F9-110B-4646-946E-B245AF113434

P698

Q36696647-2AF0F7FC-7A98-47F9-9BDC-21C5A59403B8

P921

Q36696647-77D3B0FF-397D-4BC2-B538-28D436E71168

P932

Q36696647-C25BFD68-EBAD-45FC-9010-A5BD31AEEC85

P356

P1433

Nature Materials

P1476

Combination delivery of TGF-β ...... enhances tumour immunotherapy

@en

P2093

Ann Habermann

http://www.w3.org/2001/XMLSchema#string

Anthony F Ferrandino

http://www.w3.org/2001/XMLSchema#string

David Gonzalez

http://www.w3.org/2001/XMLSchema#string

Eric Stern

http://www.w3.org/2001/XMLSchema#string

Jason Criscione

http://www.w3.org/2001/XMLSchema#string

Jason Park

http://www.w3.org/2001/XMLSchema#string

Michael Look

http://www.w3.org/2001/XMLSchema#string

Paula Licona Limon

http://www.w3.org/2001/XMLSchema#string

Ragy Ragheb

http://www.w3.org/2001/XMLSchema#string

Richard A Flavell

http://www.w3.org/2001/XMLSchema#string

P2860

The role of NKT cells in tumor immunity

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy

Specificity and versatility in tgf-beta signaling through Smads

Recent advances with liposomes as pharmaceutical carriers

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids.

Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery.

IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.

P2888

P304

895-905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NMAT3355

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229153028

http://www.w3.org/2001/XMLSchema#string

P698

22797827

http://www.w3.org/2001/XMLSchema#string

P921

P932

3601683

http://www.w3.org/2001/XMLSchema#string